Navigation Links
Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/31/2009

PORTSMOUTH, N.H., July 31 /PRNewswire/ -- Lawrence N. Gray, M.D., a board-certified plastic surgeon, and Mark Ballentyne, M.D. at Atlantic Plastic Surgery Center have selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Both physicians have been avid Artefill users the past several years due to its proven success and effectiveness for the correction of wrinkles.

Dr. Lawrence Gray said, "We've had a very pleasant experience with Artefill's ease of injection and our patients are very happy with the long lasting results. Many have recommended Artefill to their friends, which is the ultimate compliment to the product. Also, happily, we have not seen any complications."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Commenting further on the product Dr. Mark Ballentyne said, "Artefill is trouble-free to administer and because the results improve over time, instead of diminishing, our patients seem to really love it. Patients are aware that they must have a skin test and then wait a month, but they are willing to do this for the long lasting results they want."

Artefill is only offered by a select group of physicians in New Hampshire and is not available at all physician offices. Drs. Gray and Ballentyne are among the company trained and select few company sponsored physicians who have the skills and experience needed to administer the product.

Jeannine a patient of Dr. Ballentyne's said, "The folds around my mouth have always been a problem for me. Since having Artefill I feel and look as if I'm in my 30's and I'm almost 58! I love the way I look in the mirror and the results have even improved over time."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

About Atlantic Plastic Surgery Center:

Atlantic Plastic Surgery Center is the practice of New Hampshire plastic surgeon Dr. Lawrence N. Gray. He has earned a great deal of respect in both his local medical community and the national plastic surgical community through his many publications, technical skill and personal demeanor. He has a large following of satisfied patients from across New Hampshire, the United States and a number of foreign countries, who have sought him out for breast augmentation and scarless breast reduction.

Dr. Gray has received the significant honor of being only one of 15 plastic surgeons in the United States selected to offer silicone breast implants for primary augmentation. This safe, FDA approved study is a very carefully controlled process. Dr. Gray's staff is knowledgeable on the guidelines for patient participation and will carefully review them with you to determine if you qualify. For more information visit http://www.atlanticplasticsurg.com/index.html or call 1-866-264-7738.

ATTENTION MEDIA: To download Artefill patient before and after pictures visit http://www.artefill.com/content/c/beforeandafter/overview.asp.

    Contact:
    Suzanne Foley
    603-431-8819


'/>"/>
SOURCE Atlantic Plastic Surgery Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
2. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
3. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
4. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
5. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
6. General Atlantic and Hellman & Friedman Purchase HLTH Corporations Remaining Interest in Emdeon
7. National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008
8. Atlantic Street Capital Announces First Close
9. J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region
10. Z Trim Multifunctional Fiber Lightens the Menu Labeling Legislation Issue at Mid-Atlantic Food Expo, September 17 & 18
11. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ... pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, ... , Dr. Olson says the decision to support the pageant in an official ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: